In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method
about
Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophagesActivity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infectionIn vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivativesIn vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosisBacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophagesIn vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosisActivity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige miceAnticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cellsHow effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?Development potential of rifalazil.Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in miceIdentification of enzymes responsible for rifalazil metabolism in human liver microsomes.Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare complex strains isolated in Italy from AIDS and non-AIDS patients.
P2860
Q28367444-B1DAD258-CD03-4CEC-AD90-A342BE26A44FQ28369151-3EF796A3-63D6-4AE1-8C39-3862BA98FFF2Q28369155-09EA80F1-439B-4B6B-A558-0AB0692A77FDQ28369383-B2468840-6DEF-4C9C-831C-A28B4B194DFDQ28378826-9CF60948-43C8-4ACC-8D0F-0664B850FACDQ28379003-E9C17DDE-8114-412D-8CCE-73815442304DQ28379172-E87C7FFD-9F10-413E-97CA-5AC9755099F0Q28379176-6F78D75B-B265-41A3-9514-6CDE7B06EB64Q28379178-881BDA95-0443-4886-A74C-4CA50B74E6F3Q28379180-1AB94C0E-88E2-4B58-AF76-6EE5969F5A58Q35056073-05956804-84F4-4C28-B902-5BE98062BD60Q35132348-DD4FDEC3-F2EC-4976-A007-775E3CA32D70Q43505733-7E068AA2-AFA8-431C-906A-777857B23269Q44988391-79DE37E3-E6D0-4314-9624-2F086156E87C
P2860
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
In vitro antimicrobial activit ...... ined by the radiometric method
@ast
In vitro antimicrobial activit ...... ined by the radiometric method
@en
In vitro antimicrobial activit ...... ined by the radiometric method
@nl
type
label
In vitro antimicrobial activit ...... ined by the radiometric method
@ast
In vitro antimicrobial activit ...... ined by the radiometric method
@en
In vitro antimicrobial activit ...... ined by the radiometric method
@nl
prefLabel
In vitro antimicrobial activit ...... ined by the radiometric method
@ast
In vitro antimicrobial activit ...... ined by the radiometric method
@en
In vitro antimicrobial activit ...... ined by the radiometric method
@nl
P2093
P2860
P356
P1476
In vitro antimicrobial activit ...... ined by the radiometric method
@en
P2093
P2860
P356
10.1128/AAC.37.1.67
P407
P577
1993-01-01T00:00:00Z